# Fluorescent-labeled IgG for Liver Tumor Detection

> **NCT05394246** · NA · UNKNOWN · sponsor: **Chinese Academy of Sciences** · enrollment: 60 (estimated)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** FluoAB

## Key facts

- **NCT ID:** NCT05394246
- **Lead sponsor:** Chinese Academy of Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-20
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05394246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05394246, "Fluorescent-labeled IgG for Liver Tumor Detection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05394246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*